Retroperitoneal fibrosis: The clinical, laboratory, and radiographic presentation

Medicine

Volumn 88, Issue 4, 2009, Pages 202-207

  Scheel, Paul J ^a,b   Feeley, Nancy ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Nephrology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CYCLOSPORIN; METHOTREXATE; PREDNISONE; TAMOXIFEN; THYROTROPIN; HEMOGLOBIN;

ABDOMINAL AORTA; ADULT; AGED; ANOREXIA; AORTA ANEURYSM; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL EVALUATION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; EDEMA; ERYTHROCYTE SEDIMENTATION RATE; FAMILY HISTORY; FATIGUE; FEMALE; FEVER; HUMAN; HYDROCELE; HYPERTENSION; IMAGE DISPLAY; INTRAVENOUS PYELOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION TEST; KIDNEY SIZE; KIDNEY VEIN; LABORATORY DIAGNOSIS; LAPAROSCOPIC SURGERY; LUNG EMBOLISM; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PRIORITY JOURNAL; RADIODIAGNOSIS; RENAL ARTERY; RETROPERITONEAL FIBROSIS; RISK FACTOR; SCROTAL PAIN; URETER OBSTRUCTION; URETER SURGERY; WEIGHT REDUCTION; BLOOD; CLASSIFICATION; COHORT ANALYSIS; ILIAC ARTERY; METABOLISM; MIDDLE AGED; PERITONEUM; PROSPECTIVE STUDY; RADIOGRAPHY;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AORTA, ABDOMINAL; BLOOD SEDIMENTATION; COHORT STUDIES; FEMALE; HEMOGLOBINS; HUMANS; ILIAC ARTERY; MALE; MIDDLE AGED; PERITONEUM; PROSPECTIVE STUDIES; RETROPERITONEAL FIBROSIS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67651094052     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181afc439     Document Type: Article

References (35)

1. Ahmad S. Association of metoprolol and retroperitoneal fibrosis. Am Heart J. 1996;131:202-203.
2. Baker LR, Mallinson WJ, Gregory MC, Menzies E, Cattell W, Whitfield H, Hendry W, Wickham J, Joekes A. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol. 1988;60:497-503.
3. Cooksey G, Powell P, Sigh M, Yeates W. Idiopathic retroperitoneal fibrosis. A long-term review after surgical treatment. Br J Urol. 1982;54:628-631.
4. Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L, Ferretti S, Cobelli R, Moroni G, Dei Tos A, Buzio C, Vaglio A. Idiopathic retroperitoneal fibrosis. Kidney Int. 2007;72:742-753.
5. Cottin V, Brillet P, Combarnous F, Duperron F, Nunes H, Cordien I Syndrome of pleural and retrosternal "bridging" fibrosis and retroperitoneal fibrosis in patients with asbestos exposure. Thorax. 2008;63:177-179.
6. Doherty C, McGeown M, Donaldson R. Retroperitoneal fibrosis after treatment with atenolol. Br Med J. 1978;2:1786.
7. Dorr W, Hendry J. Consequential late effects in normal tissues. Radiother Oncol. 2001;61:223-231.
8. Duffy T. An anatomy lesson. N Engl J Med. 1994;331:318-320.
9. Johnson JN, McFarland JB. Retroperitoneal fibrosis after treatment with stenolol. Br Med J. 1980;280:864.
10. Lepor H, Walsh PC. Idiopathic retroperitoneal fibrosis. J Urol. 1979;122:1-6.
11. Marzano A, Rapani A, Leone N, Actis G, Rizzetto M. Treatment of idiopathic retroperitoneal fibrosis using cyclosporin. Ann Rheum Dis. 2001;60:427-428.
12. McClusky DR, Donaldson RA, McGeown MG. Oxprenolol and retroperitoneal fibrosis. Br Med J. 1980;281:1459-1460.
13. McDougal W, MacDonell R. Treatment of idiopathic retroperitoneal fibrosis by immunosuppression. J Urol. 1991;145:112-114.
14. Mitchinson M. Retroperitoneal fibrosis revisited. Arch Pathol Lab Med. 1986;110:784-786.
15. Moroni G, Gallelli B, Banfi G, Sandri S, Messa P, Ponticelli C. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. Nephrol Dial Transplant. 2006;21: 2485-2490.
16. Parums DV Brown DL, Mitchinson MJ. Serum antibodies to oxidized low density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med. 1990;114:383-387.
17. Parums DV Chadwick DR, Mitchinson MJ. The localisation of immunoglobulin in chronic periaortitis. Atherosclerosis. 1986;61: 117-123.
18. Pierce JR Jr, Trostle DC, Warner JJ. Propranolol and retroperitoneal fibrosis. Ann Intern Med. 1981;95:244.
19. Rimmer E, Richens A, Gursten M, Rees R. Retroperitoneal fibrosis associated with timolol. Lancet. 1983;1:300.
20. Scavalli AS, Spadaro A, Riccieri V Ricciuti G, Taccari E, Marini M, Zoppini A. Long-term follow up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis. Clin Rheumatol. 1995;14:481-484.
21. Scheel P, Piccini J, Rahman M, Lawler L, Jarrett T. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol. 2007;178:140-144.
22. Smith RA, Cokkinides V Brawley OW Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27-41.
23. Thompson J, Julian D. Retroperitoneal fibrosis associated with metoprolol. Br Med J. 1982;284:83-84.
24. Tiptaft R, Costello J, Paris A, Blandy J. The long-term follow up of idiopathic retroperitoneal fibrosis. Br J Urol. 1982;54:620-624.
25. Uibu T, Jarvenpaa R, Hakomaki J, Auvinen A, Honkanen E, Metsarinne K, Roto P, Saha H, Uitti J, Oska P. Asbestos-related pleural and lung fibrosis in patients with retroperitoneal fibrosis. Orphanet J Rare Dis. 2008;3:29.
26. Uibu T, Oska P, Auvinen A, Honkanen E, Metsarinne K, Saha H, Uitti J, Roto P. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet. 2004;363:1422-1426.
27. Vaglio A. Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis [Commentary]. Medicine (Baltimore). 2009;88:208-210.
28. Vaglio A, Palmisano A, Ferretti S, Alberici F, Casazza I, Salvarani C, Buzio C. Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature. Rheumatology (Oxford). 2008;47:315-318.
29. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367:241-251.
30. Van Bommel E, Hendriksz T, Huiskes A, Zeegers A. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med. 2006;144:101-106.
31. Van Bommel EFH, Jansen I, Hendriksz TR, Aarnoudse ALHJ. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore). 2009;88:193-201.
32. Van Bommel E, Siems C, Hak L, van der Veer S, Hendriksz T. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kid Dis. 2007;49:615-625.
33. Warnatz K, Keskin AG, Uhl M, Scholz C, Katzenwadel A, Vaith P, Peter H, Walker U Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis. 2005;64:828-833.
34. Weiss E, Chung T. Clinical manifestations and treatment of radiation induced fibrosis. Up-To-Date. [serial online]. 2008; version 16.3. www.Uptodate.com; accessed January 18, 2009.
35. Wolyniec W, Kozuchowska M, Sworczak K, Jezior D, Rozanska-Kluziak A, Rudka R, Rojek-Trebicka J, Rutkowski B. When can we really diagnose retroperitoneal fibrosis? Nephrol Dial Transplant. 2007;22:1786-1787.